T-Cell Depletion for Allogeneic Bone Marrow Transplantation: Impact on Graft-Versus-Host Disease, Engraftment, and Graft-Versus-Leukemia
- 1 January 1993
- journal article
- review article
- Published by Mary Ann Liebert Inc in Journal of Hematotherapy
- Vol. 2 (1), 27-42
- https://doi.org/10.1089/scd.1.1993.2.27
Abstract
No abstract availableThis publication has 96 references indexed in Scilit:
- PREVENTION OF ACUTE LETHAL GRAFT-VERSUS-HOST DISEASE IN F1 HYBRID MICE BY PRETREATMENT OF THE GRAFT WITH ANTI-NK-1.1 AND COMPLEMENTTransplantation, 1992
- IMMUNOPATHOLOGY OF EARLY GRAFT-VERSUS-HOST DISEASE—A PROSPECTIVE STUDY OF SKIN, RECTUM, AND PERIPHERAL BLOOD IN ALLOGENEIC AND AUTOLOGOUS BONE MARROW TRANSPLANT RECIPIENTSTransplantation, 1991
- Graft-Versus-Host DiseaseAnnual Review of Medicine, 1991
- Graft-versus-host disease— A histological perspectiveBlood Reviews, 1990
- Successful Allogeneic Transplantation of T-Cell–Depleted Bone Marrow from Closely HLA-Matched Unrelated DonorsNew England Journal of Medicine, 1990
- Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic NeoplasmsNew England Journal of Medicine, 1989
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- Marrow Transplantation from Related Donors Other Than HLA-Identical SiblingsNew England Journal of Medicine, 1985
- Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and CyclophosphamideNew England Journal of Medicine, 1983
- Antileukemic Effect of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 1981